Atlas Trials

Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma

Clinical trial NCT00557440 · COMPLETED

Trial details

NCT number
NCT00557440
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2007-11-01
Primary completion
2008-04-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.